Cargando…

Cenerimod, a selective S1P(1) receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren’s syndrome

BACKGROUND: Sjögren’s syndrome is a systemic autoimmune disease characterized by immune cells predominantly infiltrating the exocrine glands and frequently forming ectopic lymphoid structures. These structures drive a local functional immune response culminating in autoantibody production and tissue...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gerossier, Estelle, Nayar, Saba, Froidevaux, Sylvie, Smith, Charlotte G., Runser, Celine, Iannizzotto, Valentina, Vezzali, Enrico, Pierlot, Gabin, Mentzel, Ulrich, Murphy, Mark J., Martinic, Marianne M., Barone, Francesca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628476/ https://www.ncbi.nlm.nih.gov/pubmed/34839819 http://dx.doi.org/10.1186/s13075-021-02673-x

Ejemplares similares

Preclinical to clinical translation of cenerimod, a novel S1P(1) receptor modulator, in systemic lupus erythematosus
por: Strasser, Daniel S, et al.
Publicado: (2020)

Cenerimod, a novel selective S1P(1) receptor modulator with unique signaling properties
por: Piali, Luca, et al.
Publicado: (2017)

Attenuation of murine sclerodermatous models by the selective S1P(1) receptor modulator cenerimod
por: Kano, Miyu, et al.
Publicado: (2019)

Pharmacokinetics, Pharmacodynamics, Tolerability, and Food Effect of Cenerimod, a Selective S1P(1) Receptor Modulator in Healthy Subjects
por: Juif, Pierre-Eric, et al.
Publicado: (2017)

Lack of Effect of Cenerimod, a Selective S1P(1) Receptor Modulator, on the Pharmacokinetics of a Combined Oral Contraceptive
por: Juif, Pierre-Eric, et al.
Publicado: (2022)

Pharmacokinetics and Pharmacodynamics of Cenerimod, A Selective S1P(1)R Modulator, Are Not Affected by Ethnicity in Healthy Asian and White Subjects
por: Juif, Pierre‐Eric, et al.
Publicado: (2020)

Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions
por: Colafrancesco, Serena, et al.
Publicado: (2020)

In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P(1)) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Selective S1P(1) Receptor Modulator
por: Schlicher, Lisa, et al.
Publicado: (2022)

Phosphatidylinositol 3-kinase delta pathway: a novel therapeutic target for Sjögren’s syndrome
por: Nayar, Saba, et al.
Publicado: (2019)

Sjögren’s and non-Sjögren’s sicca share a similar symptom burden but with a distinct symptom-associated proteomic signature
por: Pucino, Valentina, et al.
Publicado: (2022)

First use of cenerimod, a selective S1P(1) receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study
por: Hermann, Viktoria, et al.
Publicado: (2019)

Correction: First use of cenerimod, a selective S1P(1) receptor modulator, for the treatment of SLE: a double-blind, randomised, placebo-controlled, proof-of-concept study
Publicado: (2020)

Probing the relevance of the accelerated aging mouse line SAMP8 as a model for certain types of neuropsychiatric symptoms in dementia
por: Bergamini, Giorgio, et al.
Publicado: (2023)

The role of non-hematopoietic stromal cells in the persistence of inflammation
por: Barone, Francesca, et al.
Publicado: (2013)

Maintaining and troubleshooting HPLC systems : a user's guide /
por: Runser, Dennis J.
Publicado: (1981)

Plasmacytosis and nephrotic syndrome revealing Sjögren’s syndrome
por: LA, Céline, et al.
Publicado: (2020)

Orbit Image Analysis: An open-source whole slide image analysis tool
por: Stritt, Manuel, et al.
Publicado: (2020)

Association of Primary Sjögren’s Syndrome and Vitamin B12 Deficiency: A Cross-Sectional Case-Control Study
por: Urbanski, Geoffrey, et al.
Publicado: (2020)

Immunofibroblasts are pivotal drivers of tertiary lymphoid structure formation and local pathology
por: Nayar, Saba, et al.
Publicado: (2019)

Not all Sicca is Sjögren's and not all Sjögren's is Sicca
por: Neumann, Melissa, et al.
Publicado: (2021)

Resilience to audiogenic seizures is associated with p-ERK1/2 dephosphorylation in the subiculum of Fmr1 knockout mice
por: Curia, Giulia, et al.
Publicado: (2013)

Electricité, de la production à la distribution
por: Pierlot, J
Publicado: (2002)

Modification of the electrical installation in Point 8
por: Pierlot, J
Publicado: (2003)

Karl Gustaf Torsten Sjögren and Sjögren-Larsson syndrome
por: Aboud, Khalid Al, et al.
Publicado: (2011)

Tertiary Lymphoid Structures: Autoimmunity Goes Local
por: Pipi, Elena, et al.
Publicado: (2018)

Improvement of Severe Fatigue Following Nuclease Therapy in Patients With Primary Sjögren’s Syndrome: A Randomized Clinical Trial
por: Posada, James, et al.
Publicado: (2020)

Sjögren’s syndrome
por: André, Fiona, et al.
Publicado: (2022)

MUC1 expression in Sjogren’s syndrome, KCS, and control subjects
por: Caffery, Barbary, et al.
Publicado: (2010)

Neuro-Sjögren: Peripheral Neuropathy With Limb Weakness in Sjögren's Syndrome
por: Seeliger, Tabea, et al.
Publicado: (2019)

Biomarkers and Diagnostic Testing for Renal Disease in Sjogren's Syndrome
por: Ramponi, Giacomo, et al.
Publicado: (2020)

Immunofibroblasts regulate LTα3 expression in tertiary lymphoid structures in a pathway dependent on ICOS/ICOSL interaction
por: Nayar, Saba, et al.
Publicado: (2022)

An Optimized and Standardized Rapid Flow Cytometry Functional Method for Heparin-Induced Thrombocytopenia
por: Runser, Anne, et al.
Publicado: (2021)

Contribution of Genetic Factors to Sjögren's Syndrome and Sjögren's Syndrome Related Lymphomagenesis
por: Nezos, Adrianos, et al.
Publicado: (2015)

Stromal Fibroblasts in Tertiary Lymphoid Structures: A Novel Target in Chronic Inflammation
por: Barone, Francesca, et al.
Publicado: (2016)

Conjunctival Inflammation in Thrombospondin-1 Deficient Mouse Model of Sjögren’s Syndrome
por: Contreras-Ruiz, Laura, et al.
Publicado: (2013)

Herbal Formula SS-1 Increases Tear Secretion for Sjögren’s Syndrome
por: Chang, Ching-Mao, et al.
Publicado: (2021)

Does HTLV-1 Infection Show Phenotypes Found in Sjögren’s Syndrome?
por: Nakamura, Hideki, et al.
Publicado: (2022)

IRF9 and XAF1 as Diagnostic Markers of Primary Sjogren Syndrome
por: Xiao, Lu, et al.
Publicado: (2022)

Treatment of Sjögren’s Syndrome with Mesenchymal Stem Cells: A Systematic Review
por: Chihaby, Najwa, et al.
Publicado: (2021)

Síndrome de Sjogren /
por: Martínez Acosta, Claudia
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_npm8s72pr44f8q0mrc7ft0hqc3